United States · Seed startup

Who invested in Cayuga Biotech

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$5.0Mraised across 1 round since 2025, from 1 source

Latest round
Seed, $5.0MDec 2025
Investors
2
See who backed them

The rounds

  1. Dec 2025
    Seed$5.0M

    Source recorded

Founders and team

From Cayuga Biotech's own website: 2 on the team.

  • Andrea Ashford-HicksChief Executive Officer*
  • Karen BoeziBoard of Directors

Everyone who backed them

SOSVVC firm1round
New York VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Cayuga Biotech as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

SideCar AngelsAngel networkPer its own site
Symbiotic VenturesVC firmPer its own site
TBD AngelsAngel networkPer its own site

Quick answers about Cayuga Biotech

Who invested in Cayuga Biotech?

Cayuga Biotech's investors include SOSV and New York Ventures.

How much has Cayuga Biotech raised?

Cayuga Biotech has raised $5.0M across 1 round since 2025.

When did Cayuga Biotech last raise?

Cayuga Biotech's most recent round was a Seed of $5.0M in Dec 2025.

What was Cayuga Biotech's biggest round?

Its most recent round, $5.0M in Dec 2025, is also its largest on record.

Who backed Cayuga Biotech first?

Cayuga Biotech's first round on record, in Dec 2025, was backed by SOSV and New York Ventures.

What stage is Cayuga Biotech at?

Cayuga Biotech's latest named round is a Seed, in Dec 2025.

Where is Cayuga Biotech based?

Cayuga Biotech is based in the United States.

Companies like Cayuga Biotech

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.